Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.

Sequeiros T, García M, Montes M, Oliván M, Rigau M, Colás E, de Torres I, Morote J, Reventós J, Doll A.

Biomed Res Int. 2013;2013:283635. doi: 10.1155/2013/283635. Epub 2013 Nov 25. Review.

PMID:
24371818
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.

Fraunholz I, Rödel C, Distel L, Rave-Fränk M, Kohler D, Falk S, Rödel F.

Radiat Oncol. 2012 Jun 14;7:88. doi: 10.1186/1748-717X-7-88.

PMID:
22697293
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Molecular targets for radiation oncology in prostate cancer.

Wang T, Languino LR, Lian J, Stein G, Blute M, Fitzgerald TJ.

Front Oncol. 2011 Jul 13;1:17. doi: 10.3389/fonc.2011.00017. eCollection 2011.

PMID:
22645712
[PubMed]
Free PMC Article
4.

Tissue biomarkers for prostate cancer radiation therapy.

Tran PT, Hales RK, Zeng J, Aziz K, Salih T, Gajula RP, Chettiar S, Gandhi N, Wild AT, Kumar R, Herman JM, Song DY, DeWeese TL.

Curr Mol Med. 2012 Jul 1;12(6):772-87. Review.

PMID:
22292443
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Progress of molecular targeted therapies for prostate cancers.

Fu W, Madan E, Yee M, Zhang H.

Biochim Biophys Acta. 2012 Apr;1825(2):140-52. doi: 10.1016/j.bbcan.2011.11.003. Epub 2011 Nov 29. Review.

PMID:
22146293
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk